A carregar...
In Reply
Sarcopenia caused by hyperthyroidism from thyroid-stimulating hormone-suppressive therapy is one possible explanation for sorafenib dose-limiting toxicity in patients with differentiated thyroid cancer (DTC). Another possible explanation is that DTC patients in the considered trial were treated appr...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AlphaMed Press
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4122478/ https://ncbi.nlm.nih.gov/pubmed/25052450 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0186 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|